Canada · Delayed Price · Currency is CAD PreveCeutical Medical Company Description
PreveCeutical Medical Inc., a health sciences company, engages in the development of options for preventive and curative therapies utilizing organic and nature identical products.
Its research and development of preventive and therapeutic products derived from organic and nature-identical compounds; synthesized Nature Identical; Sol-Gel Nose-to-Brain delivery platform for Parkinson’s disease; develops cannabinoid-based nose-to-brain delivery system for the relief of a various ailments, including pain, inflammation, seizures, and neurological disorders; peptide library synthesis, pharmacological evaluation, alongside pharmacokinetic assessment, and determinations in animal models of pain and inflammation; and non-addictive analgesic peptides for pain management.
It also involved in licensing, branding, and marketing nutraceutical and wellness products; Sol-Gel platform; and peptide program.
PreveCeutical Medical Inc. is headquartered in West Vancouver, Canada.
| Country | Canada |
| Industry | Biotechnology |
| Sector | Healthcare |
| CEO | Stephen Van Deventer |
Contact Details
Address: 5428 Marine Drive West Vancouver, BC V7W 2R2 Canada | |
| Phone | 604 416 7777 |
| Website | preveceutical.com |
Stock Details
| Ticker Symbol | PREV |
| Exchange | Canadian Securities Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CAD |
| ISIN Number | CA74143C1068 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Stephen Van Deventer | Chairman, Chief Executive Officer and Chief Financial Officer |
| Dr. Makarand Jawadekar Ph.D. | Chief Science Officer, President and Director |
| Dr. Harendra Parekh BSc., Hons I, MRPharmS, Ph.D. | Chief Research Officer |
| Dr. Francis Tavares | Chief Technology Officer |